Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
12 hedge funds and large institutions have $406K invested in Biocept, Inc. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
20% less capital invested
Capital invested by funds: $508K → $406K (-$101K)
29% less funds holding
Funds holding: 17 → 12 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$85.2K |
| 2 |
VF
Virtu Financial
New York
|
+$12.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$73K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$32K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$32K |
| 4 |
Barclays
London,
United Kingdom
|
-$31.7K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$23K |
BIOC Hedge Fund Activity: Q2 2019 in Review
12 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2019, worth a combined $406K — down 20% from $508K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BIOC and 0 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $85.2K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $73K sold.
- 12 institutional investors held Biocept, Inc. (BIOC) as of Q2 2019, down from 17 in Q1 2019.
- Funds reported $406K of Biocept, Inc. stock for Q2 2019, down 20% quarter-over-quarter.
- 0 funds opened new Biocept, Inc. positions in Q2 2019 and 5 closed out, a net change of -5 holders.
- The largest Biocept, Inc. buyer in Q2 2019 was Vanguard Group, an estimated $85.2K added.
- The largest Biocept, Inc. seller in Q2 2019 was Dimensional Fund Advisors, an estimated $73K sold.
Based on aggregated 13F filings for Q2 2019.